Convergent Chemoenzymatic Synthesis of Glycopeptides and Glycoproteins

描述（由申请人提供）：拟研究的重点是开发高效和广泛应用的化学酶方法来合成具有生物医学意义的n -糖肽和n -糖蛋白。n -链糖基化是真核生物中普遍存在的蛋白质翻译后修饰。糖蛋白在细胞粘附、肿瘤转移、病原体感染和免疫应答等许多生物学事件中发挥重要作用。共价寡糖可以深刻地影响蛋白质的结构、功能和血清半衰期。然而，具有结构明确的低聚糖的均质糖蛋白很难从天然或重组来源获得，因为它们通常是作为异质糖型的混合物生产的。为了获得用于结构/生物学研究和生物医学应用的均匀材料，我们建议系统地探索endo-？- n -乙酰氨基葡萄糖酶（ENGases）是一类特殊的内糖苷酶，用于构建n -糖肽和n -糖蛋白。最大的优点是，一些engase能够在不需要任何保护基团的情况下，一步将完整的低聚糖转移到含有glcnac的肽或蛋白质上，从而提供了一个高度收敛的途径来获得大的糖肽和糖蛋白。但迄今为止，该方法存在转糖基化率低、产物水解的风险以及仅使用天然n -聚糖作为供体底物的限制，这些底物本身难以制备。我们的初步研究表明，使用糖恶唑啉（过渡态模拟物）作为供体底物不仅扩大了底物的可用性，而且还导致高产率的转糖基化，形成大的糖肽和均匀的糖蛋白。本提案旨在通过追求五个具体目标来系统地探索新方法的范围和局限性：1)合成和检查一系列低聚糖恶唑啉作为酶转糖基化的供体底物；2)评价用于合成含复杂焦的n -糖肽和检测O-GlcNAc糖基化的新型受体底物；3)用于结构和功能研究的HIV-1 gp120大片段的全合成；4)天然和定制均质糖蛋白合成方法的开发；5)人抗体IgG-Fc均质糖型的合成与功能研究。从拟议的研究中获得的知识将最终促进以糖蛋白为基础的治疗方法的发展。

DESCRIPTION (provided by applicant): The proposed research focuses on the development of efficient and widely applicable chemoenzymatic methods for synthesizing N-glycopeptides and N-glycoproteins of biomedical significance. N-linked glycosylation is a ubiquitous posttranslational modification of proteins in eukaryotes. Glycoproteins play important roles in many biological events such as cell adhesion, tumor metastasis, pathogen infection, and immune response. The covalently linked oligosaccharides can profoundly affect proteins' structure, function, and their serum half-life. However, homogeneous glycoproteins with structural defined oligosaccharides are difficult to obtain from natural or recombinant sources, since they are typically produced as a mixture of heterogeneous glycoforms. To obtain homogeneous materials for structural/biological studies and for biomedical applications, we propose to systematically explore the potential of endo-?-N-acetylglucosaminidases (ENGases), a special class of endoglycosidases, for constructing N-glycopeptides and N-glycoproteins. The biggest advantage is that some ENGases are able to transfer an intact oligosaccharide to a GlcNAc-containing peptide or protein in a single step without the need of any protecting groups, thus providing a highly convergent route to large glycopeptides and glycoproteins. But the method has hitherto suffered with low transglycosylation yield, the risk of product hydrolysis, and the limitation to the use of only natural N-glycans as donor substrates that themselves are difficult to prepare. Our preliminary studies have shown that the use of sugar oxazolines (the transition state mimics) as donor substrates not only expanded the substrate availability, but also resulted in a high-yield transglycosylation to form large glycopeptides and homogeneous glycoproteins. This proposal intends to systematically explore the scope and limitation of the novel methodology through pursuing five specific aims: 1) synthesis and examination of a range of oligosaccharide oxazolines as donor substrates for the enzymatic transglycosylation; 2) evaluation of novel acceptor substrates for synthesizing complex fucose-containing N-glycopeptides and for detecting O-GlcNAc glycosylation; 3) total synthesis of large HIV-1 gp120 fragments for structural and functional studies; 4) exploitation of the methodology for synthesizing natural and tailor-made homogeneous glycoproteins; and 5) synthesis and functional studies of homogeneous glycoforms of human antibody IgG-Fc. The knowledge gained from the proposed research will eventually facilitate the development of glycoprotein-based therapeutics.